NeuroPace, Inc. is a leading innovator in the neuromodulation market, headquartered in Mountain View, California. The company specializes in advanced solutions for neurological disorders, with its flagship RNS System employing unique responsive brain stimulation technology to effectively reduce seizures in patients who have not responded well to conventional therapies. NeuroPace’s strong focus on research and development positions it favorably within the evolving medical device sector, presenting attractive growth opportunities for institutional investors. As the company expands its clinical applications and market presence, it is poised to significantly impact the treatment landscape for neurological conditions, underlining its potential as a compelling investment choice. Show more
Location: 455 NORTH BERNARDO AVENUE, MOUNTAIN VIEW, CA, UNITED STATES, 94043, Mountain View, CA, 94043, USA | Website: https://www.neuropace.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE
Market Cap
515.9M
52 Wk Range
$7.56 - $18.98
Previous Close
$15.49
Open
$15.79
Volume
123,188
Day Range
$15.31 - $15.98
Enterprise Value
547.1M
Cash
20.65M
Avg Qtr Burn
-1.944M
Insider Ownership
2.72%
Institutional Own.
92.62%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
